THQ Nordic has announced they’ve wholly acquired Swedish developer Experiment 101.

The studio is known for their upcoming debut title, the fantasy kung-fu RPG Biomutant. THQ Nordic now owns 100 percent of the company’s shares, as well as the IP for Biomutant.

Here’s a rundown on Biomutant, via THQ Nordic:

Biomutant is a post-apocalyptic open-world ARPG that delivers real-time melee, shooter and mutant ability action. Replayability by varied and deep character progression, exploration of three systematically generated worlds, an underworld and a small solar system, by foot, mech, air-balloon, jetski and UFO. Biomutant also features a fully customizable (MMO style) character and mutation system, bionics and creative item crafting, plus an interactive narrative featuring a contextual storyteller where the players creates their own story of survival in a vibrant colorful world.

Key Features

• Real-Time Combat: Mixes melee, guns, and abilities.
• Hugely Customizable Character: Bionics offer powerful prosthetics, while Mutations offer physical changes as well as powers.
• Automation sidekick: Customizable living robotic toys.
• Pilotable Vehicles: Customizable mech, jetski, and UFO.
• Creative crafting system: Open creation of weapons and gear.

Biomutant is launching across PC, PlayStation 4, and Xbox One sometime early next year.